The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication
Open accessAbstract
Flavopiridol (L86-8275, HMR1275) is a cyclin-dependent kinase (Cdk) inhibitor that is in clinical trials as a cancer treatment because of its antiproliferative properties. We found that the flavonoid potently inhibited transcription by RNA polymerase II in vitro by blocking the transition into productive elongation, a step controlled by P-TEFb. The ability of P-TEFb to phosphorylate the carboxyl-terminal domain of the large subunit of RNA polymerase II was inhibited by flavopiridol with a K(i) of 3 nm. Interestingly, the drug was not competitive with ATP. P-TEFb composed of Cdk9 and cyclin T1 is a required cellular cofactor for the human immunodeficiency virus (HIV-1) transactivator, Tat. Consistent with its ability to inhibit P-TEFb, flavopiridol blocked Tat transactivation of the viral promoter in vitro. Furthermore, flavopiridol blocked HIV-1 replication in both single-round and viral spread assays with an IC(50) of less than 10 nm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[6] Statistical analysis of enzyme kinetic data
Wallace Cleland, W. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)63008-2 · Cited by 1,984
Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., & Jones, K. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80939-3 · Cited by 1,249
Yamaguchi, Y., Takagi, T., Wada, T., Yano, K., Furuya, A., Sugimoto, S., Hasegawa, J., & Handa, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80713-8 · Cited by 841
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors
Gray, N. S., Wodicka, L., Thunnissen, A.-M. W. H., Norman, T. C., Kwon, S., Espinoza, F. H., Morgan, D. O., Barnes, G., LeClerc, S., Meijer, L., et al. (1998) · Science · doi:10.1126/science.281.5376.533 · Cited by 808
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
Zhu, Y., Pe’ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M. B., & Price, D. H. (1997) · Genes & Development · doi:10.1101/gad.11.20.2622 · Cited by 696
Self-citationP-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II
Price, D. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2629-2634.2000 · Cited by 679
Self-citationControl of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase
Marshall, N. F., Peng, J., Xie, Z., & Price, D. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.27176 · Cited by 662
Self-citationCarlson, B. A., Dubay, M., Sausville, E. A., Brizuela, L., & Worland, P. J. (1996) · PubMed · Cited by 580
Self-citationMarshall, N. F., & Price, D. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12335 · Cited by 560
Self-citationP-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
Mancebo, H. S. Y., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazuda, D., Price, D., et al. (1997) · Genes & Development · doi:10.1101/gad.11.20.2633 · Cited by 544
Self-citationIdentification of multiple cyclin subunits of human P-TEFb
Peng, J., Zhu, Y., Milton, J. T., & Price, D. H. (1998) · Genes & Development · doi:10.1101/gad.12.5.755 · Cited by 519
Self-citationDe Azevedo, W. F., Mueller-Dieckmann, H. J., Schulze-Gahmen, U., Worland, P. J., Sausville, E., & Kim, S. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2735 · Cited by 496
Self-citationPreclinical and Clinical Development of Cyclin-Dependent Kinase Modulators
Senderowicz, A. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.376 · Cited by 492
Self-citationGarber, M. E., Wei, P., KewalRamani, V. N., Mayall, T. P., Herrmann, C. H., Rice, A. P., Littman, D. R., & Jones, K. A. (1998) · Genes & Development · doi:10.1101/gad.12.22.3512 · Cited by 431
Senderowicz, A. M., Headlee, D., Stinson, S. F., Lush, R. M., Kalil, N., Villalba, L., Hill, K., Steinberg, S. M., Figg, W. D., Tompkins, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2986 · Cited by 403
Self-citationWada, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7395 · Cited by 354
Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275
Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., & Worland, P. J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1742 · Cited by 345
Self-citationControl of formation of two distinct classes of RNA polymerase II elongation complexes.
Marshall, N. F., & Price, D. H. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2078 · Cited by 309
Self-citationHIV-1 Tat protein promotes formation of more-processive elongation complexes.
Marciniak, R. A., & Sharp, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04997.x · Cited by 287
Carlson, B., Lahusen, T. J., Singh, S., Loaiza‐Perez, A., Worland, P. J., Pestell, R. G., Albanese, C., Sausville, E. A., & Senderowicz, A. M. (1999) · PubMed · Cited by 287
Self-citationRNA Polymerase II Elongation Control
PENG, J., LIU, M., MARION, J., ZHU, Y., & PRICE, D. H. (1998) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1998.63.365 · Cited by 238
Self-citationCyclin K Functions as a CDK9 Regulatory Subunit and Participates in RNA Polymerase II Transcription
Fu, T.-J., Peng, J., Lee, G., Price, D. H., & Flores, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34527 · Cited by 223
Self-citationA protein phosphatase functions to recycle RNA polymerase II
Cho, H., Kim, T.-K., Mancebo, H., Lane, W. S., Flores, O., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.12.1540 · Cited by 196
Tat Transactivation: A Model for the Regulation of Eukaryotic Transcriptional Elongation
Taube, R., Fujinaga, K., Wimmer, J., Barborič, M., & Peterlin, B. M. (1999) · Virology · doi:10.1006/viro.1999.9944 · Cited by 159
Self-citationUpregulation of cyclin T1/CDK9 complexes during T cell activation
Garriga, J., Peng, J., Parreño, M., Price, D. H., Henderson, E. E., & Graña, X. (1998) · Oncogene · doi:10.1038/sj.onc.1202548 · Cited by 131
Self-citationHIV-1 Tat: coping with negative elongation factors
Garber, M. E., & Jones, K. A. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80077-6 · Cited by 117
Fackler, O., Kienzle, N., Kremmer, E., Boese, A. S., Schramm, B., Klimkait, T., Kücherer, C., & Mueller‐Lantzsch, N. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00843.x · Cited by 90
Flores, O. A., Lee, G., KESSLER, J. A., Miller, M., Schlief, W., Tomassini, J. E., & Hazuda, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7208 · Cited by 71
Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 tat-activation
Wu-Baer, F., Lane, W. S., & Gaynor, R. B. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1601 · Cited by 66
Regulation of Carboxyl-terminal Domain Phosphatase by HIV-1 Tat Protein
Marshall, N. F., Dahmus, G. K., & Dahmus, M. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.31726 · Cited by 48
Highly Divergent Lentiviral Tat Proteins Activate Viral Gene Expression by a Common Mechanism
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., & Cullen, B. R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4592 · Cited by 38
Cited by
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
Targeting the Cell Cycle: A New Approach to Cancer Therapy
Schwartz, G. K., & Shah, M. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5594 · Cited by 817
Organization and regulation of gene transcription
Cramer, P. (2019) · Nature · doi:10.1038/s41586-019-1517-4 · Cited by 748
Metadata
- Authors
- Chao, S.-H., Fujinaga, K., Marion, J. E., Taube, R., Sausville, E. A., Senderowicz, A. M., Peterlin, B. M., & Price, D. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 275
- Issue
- 37
- Pages
- 28345-28348
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2147347134
- Cited by
- 455
- References
- 31
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.